Nadine Norton, PhD, Associate Professor of Cancer Biology for the Mayo Clinic in Jacksonville, FL (IMAGE)

Alliance for Clinical Trials in Oncology

Nadine Norton, PhD, Associate Professor of Cancer Biology for the Mayo Clinic in Jacksonville, FL

Caption

“We discovered that men who carry a specific version of the gene SULT2A1 clear abiraterone from their bodies more slowly,” said lead author Nadine Norton, PhD, Associate Professor of Cancer Biology for the Mayo Clinic in Jacksonville, FL. “This means the drug stays in the system longer, which could affect how well it works and whether side effects occur.”

 

Credit

Courtesy Mayo Clinic

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.